View Older Stories View More Recent Stories

Sep 29, 2021 06:45AM Positive Top-line Results of Pfizer’s Phase 3 Study Exploring Coadministration of Prevnar 20™ With Seasonal Flu Vaccine in Older Adults Released
Sep 28, 2021 06:45AM Pfizer (PFE), BioNTech (BNTX) Submit Initial Data to U.S. FDA From Pivotal Trial of COVID-19 Vaccine in Children 5 to <12 Years of Age
Sep 28, 2021 06:45AM Pfizer and BioNTech Submit Initial Data to U.S. FDA From Pivotal Trial of COVID-19 Vaccine in Children 5 to <12 Years of Age
Sep 28, 2021 01:00AM Valneva and Pfizer Report Further Positive Phase 2 Results, Including Booster Response, for Lyme Disease Vaccine Candidate
Sep 27, 2021 04:31PM Pfizer (PFE) Commences Study of mRNA-Based Flu Vaccine Program
Sep 27, 2021 04:30PM Pfizer Starts Study of mRNA-Based Next Generation Flu Vaccine Program
Sep 27, 2021 06:45AM Pfizer (PFE) Commences Global Phase 2/3 EPIC-PEP Study of Novel COVID-19 Oral Antiviral Candidate for Post-Exposure Prophylaxis in Adults
Sep 27, 2021 06:45AM Pfizer Starts Global Phase 2/3 EPIC-PEP Study of Novel COVID-19 Oral Antiviral Candidate for Post-Exposure Prophylaxis in Adults
Sep 24, 2021 04:26PM OPKO Health (OPK) and Pfizer (PFE) Extend U.S. FDA Review of Biologics License Application of Somatrogon for Pediatric Growth Hormone Deficiency
Sep 24, 2021 04:24PM Pfizer and OPKO Announce Extension of U.S. FDA Review of Biologics License Application of Somatrogon for Pediatric Growth Hormone Deficiency
Sep 23, 2021 10:00AM Pfizer Invites Public to View and Listen to Webcast of Pfizer November 2 Conference Call with Analysts
Sep 23, 2021 08:00AM Pfizer Declares Fourth-Quarter 2021 Dividend
Sep 23, 2021 05:50AM Pfizer (PFE) and BioNTech SE (BNTX) Announce FDA Emergency Use Authorization of COVID-19 Vaccine Booster
Sep 23, 2021 05:50AM Pfizer (PFE) and BioNTech SE (BNTX) Announce FDA Emergency Use Authorization of COVID-19 Vaccine Booster
Sep 22, 2021 09:44PM Pfizer and BioNTech Receive First U.S. FDA Emergency Use Authorization of a COVID-19 Vaccine Booster
Sep 22, 2021 06:04AM Pfizer (PFE), BioNTech (BNTX) in Collaboration with U.S. to Provide 500M Additional COVID-19 Vaccine Doses to Poor Nations
Sep 22, 2021 06:02AM Pfizer and BioNTech Expand Collaboration with U.S. to Provide 500 Million Additional COVID-19 Vaccine Doses at Not-for-Profit Price for Donation to Poorest Countries
Sep 20, 2021 10:00AM Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
Sep 20, 2021 06:45AM Pfizer (PFE), BioNTech (BNTX) Announce Positive Topline Results From Pivotal Trial of COVID-19 Vaccine in Children 5 to 11 Years
Sep 20, 2021 06:45AM Pfizer and BioNTech Announce Positive Topline Results From Pivotal Trial of COVID-19 Vaccine in Children 5 to 11 Years
Sep 18, 2021 03:40AM FDA Advisory Committee Votes Unanimously in Favor of COMIRNATY® Booster for Emergency Use in People 65 and Older and Certain High-Risk Populations
Sep 17, 2021 07:21PM FDA Advisory Committee Votes Unanimously in Favor Of COMIRNATY® Booster for Emergency Use in People 65 and Older and Certain High-risk Populations
Sep 9, 2021 06:59AM Myovant Sciences (MYOV), Pfizer (PFE) Announce FDA Acceptance of sNDA for MYFEMBREE for Management of Moderate to Severe Pain Associated With Endometriosis
Sep 9, 2021 06:58AM Myovant Sciences and Pfizer Announce FDA Acceptance of Supplemental New Drug Application for MYFEMBREE® for the Management of Moderate to Severe Pain Associated With Endometriosis
Sep 9, 2021 06:58AM Myovant Sciences and Pfizer Announce FDA Acceptance of Supplemental New Drug Application for MYFEMBREE® for the Management of Moderate to Severe Pain Associated With Endometriosis
Sep 9, 2021 06:46AM Pfizer (PFE) Announces UK’s MHRA Grants Marketing Authorisation for CIBINQO for Adults and Adolescents With Moderate to Severe Atopic Dermatitis
Sep 9, 2021 06:45AM UK’s MHRA Grants Marketing Authorisation for Pfizer’s CIBINQO® (abrocitinib) for Adults and Adolescents With Moderate to Severe Atopic Dermatitis
Sep 7, 2021 10:00AM Pfizer Invites Public to Listen to Two Webcasts of Pfizer Discussions at Upcoming Healthcare Conferences
Sep 2, 2021 06:54AM Pfizer (PFE) Initiates Phase 3 Trial for Investigational Vaccine Against RSV
Sep 2, 2021 06:45AM Pfizer Announces Start of Phase 3 Clinical Trial in Adults for Its Investigational Vaccine Against Respiratory Syncytial Virus (RSV)
Aug 30, 2021 06:46AM Pfizer (PFE) Announces Positive Results from Phase 3 JADE DARE Trial Comparing the Efficacy of Abrocitinib and Dupilumab for Moderate to Severe Atopic Dermatitis
Aug 30, 2021 06:45AM Positive Top-Line Results From Pfizer’s Phase 3 JADE DARE Trial Comparing the Efficacy of Abrocitinib and Dupilumab for Moderate to Severe Atopic Dermatitis
Aug 26, 2021 08:00AM Pfizer (PFE) Appoints Aamir Malik as Chief Business Innovation Officer
Aug 26, 2021 08:00AM Pfizer Announces New Chief Business Innovation Officer
Aug 26, 2021 06:47AM Pfizer (PFE) and BioNTech(BTNX) Partner With Eurofarma Laboratórios to Manufacture COVID-19 Vaccine in Latin America
Aug 26, 2021 06:46AM Pfizer and BioNTech Announce Collaboration with Brazil’s Eurofarma to Manufacture COVID-19 Vaccine Doses for Latin America
Aug 26, 2021 06:45AM Pfizer and BioNTech Announce Collaboration With Brazil’s Eurofarma to Manufacture COVID-19 Vaccine Doses for Latin America
Aug 25, 2021 12:10PM Pfizer and BioNTech Initiate Rolling Submission of Supplemental Biologics License Application to U.S. FDA for Booster Dose of COMIRNATY® in Individuals 16 and Older
Aug 25, 2021 12:09PM Pfizer (PFE), BioNTech (BNTX) Confirm Rolling Submission of sBLA to U.S. FDA for Booster Dose of Covid-19 Vaccine
Aug 25, 2021 12:08PM Pfizer and BioNTech Initiate Rolling Submission of Supplemental Biologics License Application to U.S. FDA for Booster Dose of COMIRNATY® in Individuals 16 and Older
Aug 23, 2021 11:57AM Pfizer (PFE), BioNTech SE (BNTX) Confirm Full U.S. FDA Approval for COVID-19 Vaccine
Aug 23, 2021 11:57AM Pfizer-BioNTech COVID-19 Vaccine COMIRNATY® Receives Full U.S. FDA Approval for Individuals 16 Years and Older
Aug 23, 2021 11:55AM Pfizer-BioNTech COVID-19 Vaccine COMIRNATY® Receives Full U.S. FDA Approval for Individuals 16 Years and Older
Aug 23, 2021 06:46AM Trillium Therapeutics (TRIL) Acquired by Pfizer (PFE) for $2.26B or $18.50/sh
Aug 23, 2021 06:45AM Pfizer to Acquire Trillium Therapeutics Inc.
Aug 23, 2021 06:45AM Pfizer to Acquire Trillium Therapeutics Inc.
Aug 20, 2021 04:32PM Pfizer's (PFE) XELJANZ Receives Marketing Authorization in European Union for Treatment of Active Polyarticular Juvenile Idiopathic Arthritis and Juvenile Psoriatic Arthritis
Aug 20, 2021 04:31PM XELJANZ® (tofacitinib citrate) Receives Marketing Authorization in the European Union for the Treatment of Active Polyarticular Juvenile Idiopathic Arthritis and Juvenile Psoriatic Arthritis
Aug 16, 2021 11:32AM Pfizer (PFE), BioNTech (BNTX) Announce Submission of Initial Data to U.S. FDA to Support Booster Dose of COVID-19 Vaccine
Aug 16, 2021 11:32AM Pfizer and BioNTech Announce Submission of Initial Data to U.S. FDA to Support Booster Dose of COVID-19 Vaccine
View More Recent Stories View Older Stories